Search
Selected Filter
Displaying 1–10 of 230 research results
-
ARVO 2021 Highlight: CRISPR/Cas9 Therapy Emerging for Dominant RP Caused by RP1 Mutations
Gene-editing approaches are often better suited for autosomal dominant retinal diseases than gene replacement therapies
-
ARVO 2021 Highlight: Update on Clinical Trial of jCyte’s Cellular Therapy for RP
Cellular treatment provided significant improvements in visual acuity for subpopulation of patients with better vision
-
SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
The gene-agnostic approach shows promise for people with late-stage RP and related diseases.
-
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Encouraging Early Report for Three Patients in LCA1-GUCY2D Gene Therapy Clinical Trial
Development of the emerging gene therapy is being funded by the Foundation’s RD Fund
-
Foundation Invests $5.5 Million in Seven New Translational Research Projects
Projects target a variety of conditions including: age-related macular degeneration, Stargardt disease, retinitis pigmentosa, and Usher syndrome type 3A
.png)
